Volume 14 Supplement 1

6th International Conference on cGMP: Generators, Effectors and Therapeutic Implications

Open Access

Identification of cCMP binding and activated proteins

  • Stefanie Wolfertstetter1Email author,
  • Elisabeth Schinner1,
  • Franz Hofmann2 and
  • Jens Schlossmann1
BMC Pharmacology and Toxicology201314(Suppl 1):P78

DOI: 10.1186/2050-6511-14-S1-P78

Published: 29 August 2013


cAMP and cGMP are well established second messengers and essential for numerous of (patho)physiological processes. These purine cyclic nucleotides activate PKA and PKG, respectively. So far, there was no evidence of further cyclic nucleotides acting as second messengers. Meanwhile the existence of cCMP was described [1]. Formation of the cyclic pyrimidine nucleotide cyclic cytidine 3’,5’-monophosphate (cCMP) by cytidylyl cyclases is debated. cCMP induces relaxation of vascular smooth muscle via cGKI [2]. Furthermore, it was postulated that cCMP is relevant for cell growth [3] and blood cell function [4]. However, functions regulated by cCMP are mostly unknown.


Our aim is to identify cCMP-binding and -acitvated proteins and to elucidate whether cCMP plays a role as second messenger. We confirmed that cCMP activates the purified cyclic nucleotide-dependent protein kinases cAK and cGK. Then we investigated the effect of cCMP on purified cyclic nucleotide-dependent protein kinases and on intact tissues of wildtype (WT) and cGKI-knockout (KO) mice, namely jejunum, lung and brain. We identified various protein kinases as cCMP-binding proteins in tissue lysates. cCMP stimulated cyclic GMP-dependent protein kinases in WT tissue lysates, however there was no stimulation of phosphorylation in KO tissue lysates.


These results indicate that cCMP could play a role in physiological processes in jejunum, lung and brain.

Authors’ Affiliations

Department of Pharmacology and Toxicology, University of Regensburg
FOR923, Institute for Pharmacology and Toxicology, TU


  1. Newton RP, Salih SG, Salvage BJ, Kingston EE: Extraction, purification and identification of cytidine 3',5'-cyclic monophosphate from rat tissues. Biochem J. 1984, 21: 665-673.View ArticleGoogle Scholar
  2. Desch M, Schinner E, Kees F, Hofmann F, Seifert R, Schlossmann : Cyclic cytidine 3',5'-monophosphate (cCMP) signals via cGMP kinase I. FEBS Lett. 2010, 584: 3979-3984. 10.1016/j.febslet.2010.07.059.View ArticlePubMedGoogle Scholar
  3. Cheng YC, Bloch A: Demonstration, in leukemia L-1210 cells, of a phosphodiesterase acting on 3':5'-cyclic CMP but not on 3':5'-cyclic AMP or 3':5'- cyclic GMP. J Biol Chem. 1978, 253: 2522-2524.PubMedGoogle Scholar
  4. Ervens J, Seifert R: Differential modulation by N4, 2'-O-dibutyryl cytidine 3':5'-cyclic monophosphate of neutrophil activation. Biochem Biophys Res Commun. 1991, 74: 258-267.View ArticleGoogle Scholar


© Wolfertstetter et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.